Here we provide data from a head-to-head comparison study using four biosensor platforms: GE Healthcare's Biacore T100, Bio-Rad's ProteOn XPR36, ForteBio's Octet RED384, and Wasatch Microfluidics's IBIS MX96. We used these instruments to analyze the binding interactions of a panel of ten high-affinity monoclonal antibodies with their antigen, human proprotein convertase subtilisin kexin type 9 (PCSK9). For each instrument, binding curves obtained at multiple densities of surface antibodies were fit to the 1:1 Langmuir kinetic model, and the association and dissociation rate constants and corresponding affinity constants were calculated. The data supplied in this article accompany the research article entitled, "Comparison of biosensor platforms in the evaluation of high affinity antibody-antigen binding kinetics" [1], which further discusses the strengths and weaknesses of each biosensor platform with an emphasis on data consistency, comparability, and operational efficiency.
Specifications Table

Subject area
Biosensors More specific subject area
Binding kinetic analysis
Type of data Antibodies were captured or immobilized onto the sensor surface at multiple densities, and the antigen (hu PCSK9) was flowed over the antibody surface at titrating concentrations.
Experimental features
Characterization of kinetic rate and equilibrium binding constants obtained from binding curves (10-min or 500-s association period and 45-min dissociation period) using the 1:1 Langmuir kinetic model Data source location
Department of Immune Modulation and Biotherapeutics Discovery, Boehringer
Ingelheim Pharmaceuticals, Inc., Ridgefield, CT 06877 Data accessibility
Data are within this article
Value of the data
The data enable the head-to-head comparison of four instruments' performance regarding data consistency and comparability.
The data can help new biosensor users determine the best instrument for their research purposes and maximize the value of their investment.
The data provide additional insights for current biosensor users regarding the systematic factors that influence data reliability. Table 1 contains the calculated antibody surface binding activity for the antigen obtained using three instruments (ProteOn XPR36, Biacore T100, and Octet RED384), and Tables 2 and 3 contain the association (k a ), dissociation (k d ), and equilibrium (K D ) binding constants obtained by applying the binding curves recorded using the same three instruments and the IBIS MX96. Table 4 contains the final kinetic rates and binding constants obtained from global analysis of the binding curves from multiple antibody-coated surfaces, and Table 5 contains the ratio of the instrumental limits provided by the manufacturers to the experimentally determined rate constants.
Data
Experimental design, materials and methods
Proteins and antibodies
To prepare the antigen, suspended HEK293-6E cells were transfected with a plasmid encoding Cterminally 6-His-tagged human PCSK9, using the TransIT-PRO system (Mirus Bio LLC). After a 4-day incubation, the medium was harvested, and the 6-His-tagged PCSK9 was purified using a Ni-NTA His-Bind Superflow column (Novagen), according to the manufacturer's instructions.
To prepare 20 different monoclonal antibodies (mAbs) against human PCSK9, CHO cells were transfected with plasmid DNAs containing heavy chain and light chain cassettes, using Freestyle CHO Expression Medium containing 8 mM Glutamax (Invitrogen). After a 7-day incubation, the medium was harvested, and antibodies were purified using an ÄKTA affinity chromatography system with MabSelect Sure resin (GE Healthcare), by standard procedures [2] . The purified mAbs were formulated in 60 mM sodium acetate (pH 5.0), and their concentration was determined by the adsorption at 280 nm, using a NanoDrop™ 8000 Spectrophotometer (Thermo Fischer Scientific) and an extinction coefficient of 1.36 [2] . The antibodies were determined to be 495% monomers by size exclusion ultra-performance liquid chromatography (UPLC) (ACQUITY, Waters Corporation).
Instruments and reagents
Four biosensors were used for the binding experiments: the Biacore T100 [3] , ProteOn XPR36 [4] , Octet RED384 [5] , and IBIS MX96 [6] . The Biacore T100, equipped with CM5 sensor chips, was purchased from GE Healthcare (Piscataway, NJ, USA); the ProteOn XPR36, equipped with a GLM sensor chip, from Bio-Rad (Hercules, CA, USA); the Octet RED384, equipped with AHC (anti-Human IgG Fc capture) biosensor tips, from ForteBio (Menlo Park, CA, USA); and the IBIS MX96, supplied with a CFM printer and SensEye COOH-G chip, from Wasatch Microfluidics (Salt Lake City, UT, USA). Recombinant protein A/G was from Thermo Fischer Scientific (catalog #21186). To couple the protein A/G to the biosensor surface, an amine coupling kit containing 10 mM sodium acetate (pH 4.5), 200 mM 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride (EDC), 50 mM N-hydroxysuccinimide (NHS), and 1 M ethanolamine-HCl (pH 8.5) (GE Healthcare, product #BR1000050) or the ProteOn amine coupling kit, containing 400 mM EDC, 100 mM N-hydroxysulfosuccinimide (sulfo-NHS), and 1 M ethanolamine-HCl (pH 8.5) (Bio-Rad, catalog #1762410) was used. Various regeneration solutions were tested, including 4 M MgCl 2 , 10 mM glycine-HCl (pH 2.5, pH 2.0, and pH 1.5) (GE Healthcare), and 0.85% phosphoric acid (Bio-Rad) stock diluted 1/500 (v/v) in water.
Biacore T100 kinetic measurements
Protein A/G was immobilized onto the four individual flow cells in the CM5 sensor chip by a standard coupling protocol. First, the carboxyl groups on the sensor surface were activated by injecting 200 mM EDC/50 mM NHS. Next, protein A/G (30 mg/ml in sodium acetate [pH 4.5]) was injected over the activated surface, to which it became covalently attached by its primary amines. The excess reactive esters were then blocked with 1 M ethanolamine. Each step was performed with a 7-min injection and a 5 ml/min flow rate. The flow rate was increased to 10 ml/min for the subsequent antibody-capturing step,. Each mAb, prepared at 0.063 mg/ml in HBS-EP running buffer (10 mM HEPES [pH 7.4], 150 mM NaCl, 3 mM EDTA, and 0.005% v/v polysorbate P20) was serially injected onto flow cells 2, 3, and 4 for 220 s, 110 s, and 55 s, respectively. Flow cell 1 was left empty to provide a Table 1 Antibody binding activities for human PCSK9. The slope and R 2 values were obtained from the linear regression fit of the experimental R max vs. R L correlation curves (see Fig. 4 in Ref. [1] ). The % activity was the ratio of the experimentally obtained slope to the theoretical R max /R L value, as defined by the known molar mass of the antigen and antibody (see Materials and methods). Table 3 Kinetic rates and equilibrium binding constants obtained by fitting data generated for individual antibody surfaces in the IBIS MX96 to the 1:1 interaction model (see Fig. 10 in Ref. [1] ).
mAb ID
mAb ID Array spot IBIS MX96 (amine-coupled) IBIS MX96 (Fc-captured)
6.37 Â 10 5 12.3 Â 10 À 5 0.193 2.1 3.82 Â 10 5 3.12 Â 10 À 5 0.082 5.3 25 7.51 Â 10 5 18.0 Â 10 À 5 0.239 0.9 ----37
6.38 Â 10 5 10.3 Â 10 À 5 0.161 1.1 4.97 Â 10 5 3.79 Â 10 À 5 0.076
10.0 Â 10 5 9.03 Â 10 À 5 0.090 2.2 4.87 Â 10 5 2.92 Â 10 À 5 0.060 3.0 73 15.3 Â 10 5 9.79 Â 10 À 5 0.064 1.1 6.56 Â 10 5 3.65 Â 10 À 5 0.056 2.9 85
- reference surface. To measure the binding kinetics, human PCSK9 (100-0.39 nM in 2-fold serial dilutions), and a buffer blank for baseline subtraction were sequentially injected, with a regeneration step inserted between each cycle. The protein A/G surface was regenerated with two 18-s pulses of glycine (pH 1.5) at 50 ml/min. The binding interactions were monitored over a 10-min association period and a 45-min dissociation period (running buffer only), at 30 ml/min.
ProteOn XPR36 kinetic measurements
To immobilize protein A/G onto the GLM sensor chip imprinted with 6 crisscrossing flow channels, a procedure similar to the above-described coupling method was used, except that 100 mM sulfo-NHS/400 mM EDC was used in the activation step. The activation, immobilization, and deactivation steps were each performed for 5 min with 6 parallel injections in the horizontal direction at 30 ml/ min. The protein A/G-bound surfaces were then conditioned with three 18-s pulses of glycine (pH 1.5) at 100 ml/min in the horizontal and vertical directions. Two different mAbs, each prepared at 0.25 mg/ ml, 0.125 mg/ml, and 0.063 mg/ml in PBS-T-EDTA running buffer (PBS [pH 7.4], 0.005% Tween-20, and 3 mM EDTA) were then injected in parallel in the vertical direction for 160 s at 25 ml/min. One mAb 
mAb 1 18.1 Â 10 5 3.05 Â 10 À 5 0.017 21.7 Â 10 5 5.14 Â 10 À 5 0.024 4.31 Â 10 5 0.99 Â 10 À 5 0.023 5.05 Â 10 5 3.37 Â 10 À 5 0.067 9.11 Â 10 5 11.9 Â 10 À 5 0.131 mAb 2 1.84 Â 10 5 2.42 Â 10 À 5 0.131 1.23 Â 10 5 3.44 Â 10 À 5 0.280 1.56 Â 10 5 0.10 Â 10 À 5 0.006 1.78 Â 10 5 0.10 Â 10 À 5 0.006 1.26 Â 10 5 0.45 Â 10 À 5 0.036 mAb 3 20.8 Â 10 5 24.7 Â 10 À 5 0.119 20.0 Â 10 5 35.6 Â 10 À 5 0.178 4.54 Â 10 5 12.7 Â 10 À 5 0.279 4.74 Â 10 5 24.1 Â 10 À 5 0.508 7.03 Â 10 5 40.9 Â 10 À 5 0.582 mAb 4 5.36 Â 10 5 21.3 Â 10 À 5 0.398 4.79 Â 10 5 23.5 Â 10 À 5 0.491 4.00 Â 10 5 8.46 Â 10 À 5 0.211 1.49 Â 10 5 8.90 Â 10 À 5 0.597 2.39 Â 10 5 38.2 Â 10 À 5 1.600 mAb 5 0.73 Â 10 5 3.86 Â 10 À 5 0.530 0.60 Â 10 5 7.04 Â 10 À 5 1.170 0.84 Â 10 5 0.50 Â 10 À 5 0.059 0.38 Â 10 5 1.79 Â 10 À 5 0.471 0.38 Â 10 5 4.11 Â 10 À 5 1.080 mAb 6 2.25 Â 10 5 7.25 Â 10 À 5 0.322 0.72 Â 10 5 6.44 Â 10 À 5 0.894 1.76 Â 10 5 3.21 Â 10 À 5 0.182 0.38 Â 10 5 5.67 Â 10 À 5 1.490 0.86 Â 10 5 13.5 Â 10 À 5 1.570 mAb 7 1.76 Â 10 5 14.2 Â 10 À 5 0.807 1.04 Â 10 5 15.0 Â 10 À 5 1.440 1.80 Â 10 5 10.2 Â 10 À 5 0.567 0.54 Â 10 5 17.0 Â 10 À 5 3.150 1.32 Â 10 5 25.4 Â 10 À 5 1.920 mAb 8 4.56 Â 10 5 19.4 Â 10 À 5 0.425 7.34 Â 10 5 35.0 Â 10 À 5 0.477 3.31 Â 10 5 7.02 Â 10 À 5 0.212 1.20 Â 10 5 23.0 Â 10 À 5 1.920 3.68 Â 10 5 29.4 Â 10 À 5 0.800 mAb 9 6.52 Â 10 5 5.84 Â 10 À 5 0.090 2.20 Â 10 5 8.82 Â 10 À 5 0.401 3.69 Â 10 5 0.10 Â 10 À 5 0.003 2.25 Â 10 5 6.89 Â 10 À 5 0.306 3.18 Â 10 5 11.7 Â 10 À 5 0.368 mAb 10
1.53 Â 10 5 9.50 Â 10 À 5 0.621 1.22 Â 10 5 23.1 Â 10 À 5 1.890 1.73 Â 10 5 3.72 Â 10 À 5 0.215 0.46 Â 10 5 9.03 Â 10 À 5 1.960 0.52 Â 10 5 17.3 Â 10 was injected into channels 1-3, and the other into channels 4-6. The orientation of the sensor chip was then switched, and a buffer blank was injected for 60 s. The antigen-binding kinetics of the mAbs in the six samples was measured by simultaneously injecting five human PCSK9 samples at different concentrations in running buffer and a buffer blank. Three different series of human PCSK9 concentration ranges (100-6.25 nM, 25-1.56 nM, and 5-0.313 nM), prepared by 2-fold serial dilution, were used. The binding was monitored over a 10-min association period and a 45-min dissociation period (running buffer only) at 40 ml/min. After each binding cycle, the protein A/G surface was regenerated with two 18-s pulses of glycine (pH 1.5) at 100 ml/min in the horizontal and vertical directions.
Octet RED384 kinetic measurements
Each mAb was prepared at 20 mg/ml, 10 mg/ml, and 5 mg/ml in 1 Â KB running buffer (PBS pH [7.4] , 0.02% Tween-20, 0.1% albumin, and 0.05% sodium azide) and dispensed into a 384-well tilted-bottom microplate (90 ml per well). Eight vertical wells were used for each concentration. A second 384-well microplate contained human PCSK9 at 7 different concentrations (100-1.56 nM, in 2-fold serial dilutions), the glycine [pH 1.5] regeneration solution, and 1 Â KB buffer for baseline stabilization. Both plates were agitated at 1000 rpm during the entire experiment. Sixteen AHC (anti-human Fc capture) sensor tips were used for a group of 2 mAbs (8 sensors each) per binding cycle. Before the binding measurements, the sensor tips were pre-hydrated in 1 Â KB for 5 min, followed by 3 pre-conditioning cycles consisting of 15-s dips in glycine (pH 1.5) alternating with 15-s dips in 1 Â KB. The sensor tips were then transferred to the mAb-containing wells for a 200-s loading step. After a 60-s baseline dip in 1 Â KB, the binding kinetics were measured by dipping the mAb-coated sensors into the wells containing human PCSK9 at various concentrations. The binding interactions were monitored over a 500-s association period, followed by a 30-min dissociation period, in which the sensors were dipped into new wells containing 1 Â KB buffer only. The AHC sensor tips were regenerated with two 18-s dips in glycine (pH 1.5) between each binding cycle.
2.6. IBIS MX96 kinetic measurements 2.6.1. Multi-cycle kinetics with amine-coupled antibody arrays
For multi-array printing with the CFM, two 96-well microplates were prepared. The sample source plate contained 8 vertical wells of each mAb in sodium acetate (pH 5.0) at concentrations ranging from 20 mg/ml to 0.16 mg/ml in 2-fold serial dilutions, and the reagent plate contained freshly prepared 400 mM EDC/100 mM sulfo-NHS. The COOH-G SensEye chip in the CFM was primed with sodium acetate (pH 5.0) running buffer, the sensor surface was then activated with the EDC/sulfo-NHS for 5 min, and the mAbs were then directly immobilized onto the activated surface. In the immobilization step, the mAb samples in the top half of the source plate were delivered to the sensor using 48 micro-channels, by which the mAbs were cycled across the activated surface bidirectionally for 10 min. The procedure was repeated for the remaining mAb samples in the bottom half of the source plate, generating a 10 Â 8 array of mAb spots on the sensor surface. Two vertical columns of buffercontaining wells served as reference samples. The printed sensor chip was then inserted into the MX96 instrument and primed with the system running buffer (PBS [pH 7.4], 0.01% Tween-20). The surfaces were then quenched with 1 M ethanolamine for 5 min. For the binding measurements, human PCSK9 at 9 different concentrations (0.39-100 nM in 2-fold serial dilutions) in running buffer was cycled across the mAb array surface. Each sequentially injected sample was monitored for a 10-min association period followed by a 45-min dissociation period, at a flow rate of 40 ml/min. The amine-coupled mAb surfaces were regenerated between each binding cycle with glycine (pH 2.0 or pH 2.5). These regeneration conditions were determined in a preliminary experiment.
Single-cycle kinetics with Fc-captured antibody arrays
A SensEye COOH-G chip was inserted into the MX96 instrument and primed with sodium acetate (pH 5.0). The sensor surface was activated by injecting 400 mM EDC/100 mM sulfo-NHS for 5 min, and then 50 mg/ml protein A/G in sodium acetate (pH 5.0) was cycled bidirectionally across the activated surface for 5 min. The sensor chip with the immobilized protein A/G surface was then removed from the MX96 and inserted into the CFM printer, which had been loaded with a 96-well mAb source plate. The same plate layout and mAb concentrations described above for the aminecoupled antibody array were used, but the mAbs were prepared in a system running buffer consisting of 0.01% Tween-20 in PBS. The mAb samples were captured by cycling them across the protein A/G surface for 10 min, then the sensor chip was inserted back into the MX96 instrument and primed with the system running buffer. The binding was measured by cycling human PCSK9 prepared at 7 different concentrations (1.56-100 nM in 2-fold serial dilutions) in the system running buffer. The cycling of each sequentially injected sample was monitored as described in the previous section. No regeneration was performed between sample injections.
Data analysis
Data processing and curve fitting
The binding sensorgrams were all collected at 25°C. Before the curve-fitting analysis, the acquired data were processed as follows. The Biacore T100 data were double-referenced using reference flow cell 1 and the subtraction of a preceding buffer blank with BiaEvaluation (v.4.1), and the ProteOn XPR36 data were double-referenced using channel inter-spots and subtraction of a parallel in-line buffer blank by the integrated ProteOn Manager software (v.3.1.0.6). The Octet RED384 data were referenced by subtracting a parallel buffer blank, and the baseline was aligned with the y-axis and smoothed by a Savitzky-Golay filter in the data analysis software (v.9.0.0.4). The IBIS MX96 data underwent inter-spot reference subtraction, followed by y-axis alignment using the IBIS SPRint software (v.6.15.2.1). The calibrated data were then exported to Scrubber (v.2.0c) for cropping, aligning, and buffer referencing.
The processed binding curves from the four instruments were all fitted to the Langmuir model for a 1:1 binding stoichiometry. In the Biacore T100, "single mode" was used for the fitting of data from individual mAb surfaces, and "batch mode" with "local" R max was used for the global fitting of data from multiple mAb surfaces. In the ProteOn XPR36, the "grouped" and "global" modes and the "local" R max were used for the fitting of data from single vs. multiple surfaces. In the Octet RED384, "R max linked" was used for the group fitting of data from sensors coated with the same mAb concentration, and "R max unlinked by sensor" was used for the global fitting of data from sensors coated with multiple mAb concentrations. Both the multi-cycle and single-cycle kinetic data from the IBIS MX96 were analyzed using Scrubber (v.2.0c). The k d was first determined by fitting the data in the absence of k a , then the k a k d was determined keeping the k d fixed. The fit was then further refined by floating the k d . For single-cycle kinetic data, the injection start time was set as a floating parameter, and the association profiles were fit back to a theoretical baseline origin. In all of the analyses, k a is the association rate constant for the antibody-antigen binding reaction, k d is the dissociation rate constant for the antibody-antigen complex, and K D is the equilibrium dissociation constant defined by k d / k a . The fitting accuracy was described by Chi 2 (Biacore T100, ProteOn XPR36, and IBIS MX96) or X 2 (Octet RED384), a parameter representing how well the observed results resemble those calculated from the model used to analyze the data.
Ligand surface activity
The binding activity of surface-bound mAbs toward human PCSK9, called the % ligand activity, was calculated using the following equations:
where the theoretical R max (the binding capacity of the surface) was determined as follows:
where MW was the molecular weight of the ligand (mAb, 150 kDa) and analyte (human PCSK9, 72.8 kDa), R L (ligand response) was the amount of immobilized ligand in response units (RU), and S M was the stoichiometry defined by the number of binding sites on the ligand. Rearranging the equation provides the calculation for the ligand density to aim for in the experiments:
For the kinetic binding measurements, R max was set at 50-200 RU.
